Ассоциация ОНП Pro12Ala (rs1801282) гена PPARG с уровнем мРНК в интраабдоминальной жировой ткани у женщин
Аннотация
Ключевые слова
Об авторах
А. Э. КопытоваРоссия
М. А. Николаев
Россия
Т. С. Усенко
Россия
В. В. Мирошникова
Россия
Е. А. Баженова
Россия
О. А. Беркович
Россия
Е. И. Баранова
Россия
Д. Л. Бровин
Россия
А. А. Пантелеева
Россия
И. А. Семенова
Россия
О. Д. Беляева
Россия
С. Н. Пчелина
Россия
Список литературы
1. Mendis S. Global atlas on cardiovascular disease prevention and control 2011. World Health Organization. 2013. URL: http://www.who.int/cardiovascular_diseases/
2. Halberg N, Wernstedt I, Scherer PE. The Adipocyte as an Endocrine Cell. Endocrinol. Metab. Clin. North Am. 2008; 37(3):753-768. DOI: 10.1016/j.ecl.2008.07.002.
3. Wajchenberg BL, Giannella-Neto D, da Silva ME, et al. Depotspecific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm. Metab. Res. 2002;34:616-621. DOI: 10.1055/s-2002-38256.
4. Grygiel-Gorniak. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review. Nutr J. 2014;13:17. DOI: 10.1186/1475-2891-13-17.
5. Jeninga, EH, Gurnell, M, Kalkhoven E. Functional implications of genetic variation in human PPARg. Trends Endocrinol. Metab. 2009;20:380-387. DOI: 10.1016/j.tem.2009.04.005
6. Gema Medina-Gomez, Sarah L. Gray, Laxman Yetukuri, et al. PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism. PLoS Genet. 2007;3(4):634-647. DOI: 10.1371/journal.pgen.0030064.
7. Chistiakov DA. The PPARg Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjects. 2010;(7):156-62. DOI: 10.1177/1479164109347689.
8. Gonzalez Sanchez JL, Serrano Rios M., Fernandez Perez C., et al. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur. J. Endocrinol. 2002;147:495-501. URL: http://www.eje.org.
9. Costa V, Gallo MA, Letizia F, et al. PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues. PPAR Research. 2010;2010:17. DOI:10.1155/2010/409168.
10. Doney A, Fischer B, Frew D, et al. Haplotype analysis of the PPARg Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genetics. 2002;3:21. DOI:10.1186/1471-2156-3-21.
11. Capaccio D, Ciccodicola A, Sabatino L, et al. A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia. Biochim Biophys Acta. 2010; 1802(6):572-81. DOI: 10.1016/j.bbadis.2010.01.012
12. Agostini M, Schoenmakers E, Mitchell C, et al. Non-DNA binding, dominant-negative, human PPARg mutations cause lipodystrophic insulin resistance. Cell Metabolism. 2006;4(4):303-311. doi:10.1016/j.cmet.2006.09.003.
13. http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf
14. Berhouma R, Kouidhi S, Ammar M, et al. Correlation of Peroxisome Proliferator-Activated Receptor (PPAR-g) mRNA Expression with Pro12Ala Polymorphism in Obesity. Biochem Genet. 2013;(51):256-263. DOI: 10.1007/s10528-012-9560-y.
15. Усенко ТС, Мирошникова ВВ, Баженова ЕА и др. Экспрессия генов ITLN1, PPARg и TNFa в интраабдоминальной жировой ткани. Цитология. 2016 (в печати)
16. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARc2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:284-287. DOI: 10.1038/3099.
17. Rosen ED, Hsu C-H, Wang X, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002;16(1):22-26. DOI: 10.1101/gad.948702.
18. Lee J-E, Ge K. Transcriptional and epigenetic regulation of PPARg expression during adipogenesis. Cell Biosci. 2014;4(1):29-39. DOI: 10.1186/2045-3701-4-29.
19. Zarebska A, Jastrzebski Z, Cieszczyk P, et al. The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women. PPAR Res. 2014;7. DOI: 10.1155/2014/373782.
20. Li Y, Zhu J, Ding JQ. Association of the PPARg2 Pro12Ala polymorphism with increased risk of cardiovascular diseases. Genet. Mol. Res. 2015;14(4):18662-18674. DOI: 10.4238/2015.
Рецензия
Для цитирования:
Копытова А.Э., Николаев М.А., Усенко Т.С., Мирошникова В.В., Баженова Е.А., Беркович О.А., Баранова Е.И., Бровин Д.Л., Пантелеева А.А., Семенова И.А., Беляева О.Д., Пчелина С.Н. Ассоциация ОНП Pro12Ala (rs1801282) гена PPARG с уровнем мРНК в интраабдоминальной жировой ткани у женщин. Медицинская генетика. 2017;16(2):26-29.
For citation:
Kopytova A.E., Nikolaev M.A., Usenko T.S., Miroshnikova V.V., Bazhenova E.A., Berkovich O.A., Baranova E.I., Brovin D.L., Panteleeva A.A., Semenova I.A., Belyaeva O.D., Pchelina S.N. Association of Pro12Ala (rs1801282) PPARG with PPARG mRNA levels in visceral abdominal tissue in females. Medical Genetics. 2017;16(2):26-29. (In Russ.)